AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples